These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 19068269)

  • 1. Conventional therapy with an ACE inhibitor diminishes left ventricular dyssynchrony during the progression of heart failure.
    Kurita T; Onishi K; Dohi K; Takamura T; Fujimoto N; Tanigawa T; Imanaka-Yoshida K; Wada H; Nobori T; Ito M
    Int J Cardiol; 2010 Apr; 140(1):48-54. PubMed ID: 19068269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular basis for improved left ventricular pump function after digoxin therapy in experimental left ventricular failure.
    McMahon WS; Holzgrefe HH; Walker JD; Mukherjee R; Arthur SR; Cavallo MJ; Child MJ; Spinale FG
    J Am Coll Cardiol; 1996 Aug; 28(2):495-505. PubMed ID: 8800131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal sympathetic denervation inhibits the development of left ventricular mechanical dyssynchrony during the progression of heart failure in dogs.
    Hu W; Zhao QY; Yu SB; Sun B; Chen L; Cao S; Guo RQ
    Cardiovasc Ultrasound; 2014 Nov; 12():47. PubMed ID: 25416926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibition and angiotensin II subtype-1 receptor blockade during the progression of left ventricular dysfunction: differential effects on myocyte contractile processes.
    Spinale FG; Holzgrefe HH; Mukherjee R; Webb ML; Hird RB; Cavallo MJ; Powell JR; Koster WH
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1082-94. PubMed ID: 9399980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model.
    Zhang Y; Popovic ZB; Bibevski S; Fakhry I; Sica DA; Van Wagoner DR; Mazgalev TN
    Circ Heart Fail; 2009 Nov; 2(6):692-9. PubMed ID: 19919995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure.
    Matsumoto T; Wada A; Tsutamoto T; Ohnishi M; Isono T; Kinoshita M
    Circulation; 2003 May; 107(20):2555-8. PubMed ID: 12742989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction.
    Foster RE; Johnson DB; Barilla F; Blackwell GG; Orr R; Roney M; Stanley AW; Pohost GM; Dell'Italia LJ
    Am Heart J; 1998 Aug; 136(2):269-75. PubMed ID: 9704689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
    Badano LP; Albanese MC; De Biaggio P; Rozbowsky P; Miani D; Fresco C; Fioretti PM
    J Am Soc Echocardiogr; 2004 Mar; 17(3):253-61. PubMed ID: 14981424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.
    Bax JJ; Bleeker GB; Marwick TH; Molhoek SG; Boersma E; Steendijk P; van der Wall EE; Schalij MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1834-40. PubMed ID: 15519016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular dyssynchrony resulting from right ventricular apical pacing: relevance of baseline assessment.
    Pastore G; Noventa F; Piovesana P; Cazzin R; Aggio S; Verlato R; Zanon F; Baracca E; Roncon L; Padeletti L; Barold SS
    Pacing Clin Electrophysiol; 2008 Nov; 31(11):1456-62. PubMed ID: 18950303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac resynchronization therapy in patients with a narrow QRS complex.
    Bleeker GB; Holman ER; Steendijk P; Boersma E; van der Wall EE; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2006 Dec; 48(11):2243-50. PubMed ID: 17161254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
    Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
    J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
    Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
    Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction.
    Ahmad M; White R; Tan J; Huang BS; Leenen FH
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):565-72. PubMed ID: 18496146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of long-term treatment with enalapril, losartan and their combination on the quality of life of patients with congestive heart failure].
    Vizir VA; Berezin AE
    Ter Arkh; 2002; 74(1):52-5. PubMed ID: 11878061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure in elderly patients.
    Aronow WS
    Heart Dis; 2003; 5(4):279-94. PubMed ID: 12877761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avoidance of right ventricular pacing in cardiac resynchronization therapy improves right ventricular hemodynamics in heart failure patients.
    Lee KL; Burnes JE; Mullen TJ; Hettrick DA; Tse HF; Lau CP
    J Cardiovasc Electrophysiol; 2007 May; 18(5):497-504. PubMed ID: 17428272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of heart failure and left ventricular systolic dysfunction after cardiac pacing in patients with preserved left ventricular systolic function.
    Kachboura S; Ben Halima A; Fersi I; Marrakchi S; Zouaoui W; Kammoun I
    Ann Cardiol Angeiol (Paris); 2008 Feb; 57(1):29-36. PubMed ID: 18062936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.